Astrazeneca shot shows no increased clot risk after two doses
Blot clots are not more likely after second Astrazeneca jab, data published in The Lancet suggests.
By Deirdre Hipwell and Suzi Ring, Bloomberg
Astrazeneca's covid-19 vaccine doesn't raise the risk of a rare blood clotting disorder after a second dose, suggesting people shouldn't hesitate to get another one if they didn't have trouble after the first.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Sweden phases out AstraZeneca's covid-19 vaccine
For subscribers
